W Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Wayfair is breaking down toward support with bearish momentum (negative/expanding MACD) and weak near-term pattern odds (model suggests further downside over 1W/1M). While Wall Street tone has improved and tariff pressure looks less severe, the current tape is risk-off and an executive’s planned sale is an added overhang. For an impatient buyer, the odds favor a better entry after price stabilizes back above ~$103–$110 or post-earnings (2026-02-19).
Trend/Momentum: Bearish-to-neutral near term. MACD histogram is -1.282 and negatively expanding (downside momentum increasing). RSI(6) ~25.46 reads oversold, but oversold can persist in a downswing. Levels: Price $102.55 is essentially at/just below S1 ~$103.08; if that fails, next support is S2 ~$98.86. Pivot is ~$109.91 (regaining/holding above this would improve structure). Resistance levels: R1 ~$116.74 then R2 ~$120.96. Moving averages: Converging MAs suggest consolidation after a drop, but the momentum indicator (MACD) currently favors downside continuation. Pattern-based odds: Similar-pattern model indicates ~50% chance of -2.31% next day, -3.55% next week, -8.71% next month—skewed negative.
Intellectia Proprietary Trading Signals
Analyst/Street momentum improving: Barclays upgrade to Overweight (PT $123); Truist Buy (PT $120); Oppenheimer PT raised to $144; Guggenheim PT $125—collectively supportive if execution continues.
Tariff relief narrative: Mizuho highlighted delayed/higher-tariff avoidance as “breathing room” for the category, potentially improving demand/margins versus prior fears.
Upcoming catalyst: QDEC 2025 earnings on 2026-02-19 (pre-market). If results confirm improving profitability/cash generation, the stock can re-rate quickly from oversold levels.
increases probability of a flush toward ~$
Executive selling overhang: News indicates Shah Niraji plans to sell 150,000 shares (~$16.33M), and has reduced holdings significantly since Oct 2025—often a short-term sentiment drag.
Latest reported quarter: 2025/Q3. Revenue grew to $3.117B (+8.08% YoY), showing top-line reacceleration. Losses narrowed (Net income -$99M, +33.78% YoY improvement; EPS -$0.76, +26.67% YoY improvement), indicating better cost discipline/operating leverage. However, gross margin slipped to 29.96% (-1.02% YoY), which is the key watch item—margin durability will matter most into the 2026 setup.
Recent trend: Net positive. Multiple firms raised targets/kept bullish stances (Oppenheimer PT to $144; Guggenheim PT to $125; Truist Buy $120), and Barclays upgraded to Overweight with PT $123. Mizuho reiterated Outperform on tariff-delay optimism. Offsetting view: Jefferies downgraded to Hold (PT $94) citing weaker traffic/holiday signals and more balanced risk/reward. Wall Street pros: Share gains/replatforming benefits, loyalty/marketing improvements, and potential margin/cash flow inflection. Wall Street cons: Demand sensitivity to consumer conditions, holiday/traffic softness risk, and margin pressure (gross margin down YoY). Positioning/ownership notes: Hedge funds and insiders show no broad recent trend (neutral), but the disclosed executive sale is a localized negative signal. Political/congress trades: No recent congress trading data available; no politician activity flagged in the provided data.
